Dernières nouvelles pour Liberty Global (NASDAQ:LBTYK) Stock

Liberty Global is a holding company with interests in several telecom companies in the UK, Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty is the owner of the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile-network-operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.

Liberty Global Ltd. - Class C Common Shares

Liberty Global Ltd

<p>A report on January 22, 2025 shows that Representative Thomas Kean from New Jersey purchase stock in Prologis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLD#NYSE">PLD</a>), valued between $1,001 and $15,000. According to the January filing, the transaction occurred on January 22, 2025.</p>
<p>At the time of writing, Prologis shares are trading up 2.7% at $118.24.</p>
<h3>Representative's Recent Trading Activity</h3>
<p>In the last three years, Thomas Kean completed 68 stock transactions totaling more than $320 thousand. Aon and Johnson &amp; Johnson stocks were among the largest trades. Some of the most notable transactions the Rep. has executed recently include: </p>
<ul>
<li><strong>Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYK#NASDAQ">LBTYK</a>):</strong> $15,001 - $50,000 Purchase</li>
<li><strong>Canadian Pacific Kansas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CP#NYSE">CP</a>):</strong> $1,001 - $15,000 Purchase</li>
<li><strong>Pernod Ricard (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PRNDY#OTC">PRNDY</a>):</strong> $1,001 - $15,000 Sale</li>
</ul>
<p>Here's a summary of Thomas Kean's recent trades:</p>
<table>
<thead>
<tr>
<th><strong>Company</strong></th>
<th><strong>Ticker</strong></th>
<th><strong>Stock Type</strong></th>
<th><strong>Amount</strong></th>
<th><strong>Transaction Type</strong></th>
<th><strong>Transaction Date</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Canadian Pacific Kansas</td>
<td>CP</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-27</td>
</tr>
<tr>
<td>Pernod Ricard</td>
<td>PRNDY</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S</td>
<td>2024-12-27</td>
</tr>
<tr>
<td>Alphabet</td>
<td>GOOG</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S</td>
<td>2024-12-19</td>
</tr>
<tr>
<td>Abbott Laboratories</td>
<td>ABT</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-16</td>
</tr>
<tr>
<td>Franklin Resources</td>
<td>BEN</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S (Partial)</td>
<td>2024-12-16</td>
</tr>
</tbody>
</table>
<p>Stay informed on Thomas Kean's trades and other members of Congress with our real-time <a href="https://www.benzinga.com/gov-trades/members/thomas-kean"><strong>government trades tracking tool</strong></a>!</p>
<h3>The Importance of Congressional Transactions</h3>
<p>A congressional transaction is when any representative or senator either buys or sells an individual stock.</p>
<p>Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.</p>
<p>In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.</p>
<h3>The Importance of Congressional Transactions</h3>
<p>Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.</p>
<p>When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.</p>
<p>A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Government

News

Politics

Trading Ideas

General

LBTYK

PERNOD RICARD S A SP/ADR by Pernod Ricard S.A.

PRNDY

New Jersey Rep. Thomas Kean Bought Up to $15K Worth of Prologis Stock

<p>Records from January 22, 2025 indicate that Representative Thomas Kean of New Jersey made a sale of Pernod Ricard (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PRNDY#OTC">PRNDY</a>), valued between $1,001 and $15,000, with the transaction dated January 22, 2025 and filed in January.</p>
<p>As of now, Pernod Ricard shares are trading up 0.14% at $21.96.</p>
<h3>What Representative Has Been Trading Recently</h3>
<p>Over the previous three years, Thomas Kean conducted 68 trades, totaling more than $320 thousand. The largest of these were in Aon and Johnson &amp; Johnson stock. Some of the most notable transactions the Rep. has executed recently include: </p>
<ul>
<li><strong>Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYK#NASDAQ">LBTYK</a>):</strong> $15,001 - $50,000 Purchase</li>
<li><strong>Canadian Pacific Kansas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CP#NYSE">CP</a>):</strong> $1,001 - $15,000 Purchase</li>
<li><strong>Pernod Ricard (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PRNDY#OTC">PRNDY</a>):</strong> $1,001 - $15,000 Sale</li>
</ul>
<p>Here's a summary of Thomas Kean's most recent trades:</p>
<table>
<thead>
<tr>
<th><strong>Company</strong></th>
<th><strong>Ticker</strong></th>
<th><strong>Stock Type</strong></th>
<th><strong>Amount</strong></th>
<th><strong>Transaction Type</strong></th>
<th><strong>Transaction Date</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Canadian Pacific Kansas</td>
<td>CP</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-27</td>
</tr>
<tr>
<td>Pernod Ricard</td>
<td>PRNDY</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S</td>
<td>2024-12-27</td>
</tr>
<tr>
<td>Alphabet</td>
<td>GOOG</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S</td>
<td>2024-12-19</td>
</tr>
<tr>
<td>Abbott Laboratories</td>
<td>ABT</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-16</td>
</tr>
<tr>
<td>Franklin Resources</td>
<td>BEN</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S (Partial)</td>
<td>2024-12-16</td>
</tr>
</tbody>
</table>
<p>To stay updated on Thomas Kean's trades and other congressional trades, try our <a href="https://www.benzinga.com/gov-trades/members/thomas-kean"><strong>government trades tool</strong></a> for live updates!</p>
<h3>The Importance of Congressional Transactions</h3>
<p>A congressional transaction is when any representative or senator either buys or sells an individual stock.</p>
<p>Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.</p>
<p>In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.</p>
<h3>The Importance of Congressional Transactions</h3>
<p>Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.</p>
<p>When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.</p>
<p>A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Congressional Trading Report: Rep. Thomas Kean Sold Over $1K In Pernod Ricard Stock

<p>A report on January 22, 2025 shows that Representative Thomas Kean from New Jersey sale stock in Franklin Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>), valued between $1,001 and $15,000. According to the January filing, the transaction occurred on January 22, 2025.</p>
<p>At the time of writing, Franklin Resources shares are trading up 0.2% at $19.91.</p>
<h3>Representative's Recent Trading Activity</h3>
<p>Over the past three years, Thomas Kean executed 68 trades totaling over $320 thousand. The largest of these trades were in Aon and Johnson &amp; Johnson stock. Some of the key transactions the Rep. has executed recently include: </p>
<ul>
<li><strong>Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYK#NASDAQ">LBTYK</a>):</strong> $15,001 - $50,000 Purchase</li>
<li><strong>Canadian Pacific Kansas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CP#NYSE">CP</a>):</strong> $1,001 - $15,000 Purchase</li>
<li><strong>Pernod Ricard (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PRNDY#OTC">PRNDY</a>):</strong> $1,001 - $15,000 Sale</li>
</ul>
<p>Here is a list of Thomas Kean's most recent trades:</p>
<table>
<thead>
<tr>
<th><strong>Company</strong></th>
<th><strong>Ticker</strong></th>
<th><strong>Stock Type</strong></th>
<th><strong>Amount</strong></th>
<th><strong>Transaction Type</strong></th>
<th><strong>Transaction Date</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Canadian Pacific Kansas</td>
<td>CP</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-27</td>
</tr>
<tr>
<td>Pernod Ricard</td>
<td>PRNDY</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S</td>
<td>2024-12-27</td>
</tr>
<tr>
<td>Alphabet</td>
<td>GOOG</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S</td>
<td>2024-12-19</td>
</tr>
<tr>
<td>Abbott Laboratories</td>
<td>ABT</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-16</td>
</tr>
<tr>
<td>Franklin Resources</td>
<td>BEN</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S (Partial)</td>
<td>2024-12-16</td>
</tr>
</tbody>
</table>
<p>Stay informed on Thomas Kean's trades and other members of Congress with our real-time <a href="https://www.benzinga.com/gov-trades/members/thomas-kean"><strong>government trades tracking tool</strong></a>!</p>
<h3>Why Congressional Transactions Matter</h3>
<p>A congressional transaction is when any representative or senator either buys or sells an individual stock.</p>
<p>Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.</p>
<p>In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.</p>
<h3>The Importance of Congressional Transactions</h3>
<p>Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.</p>
<p>When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.</p>
<p>A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Recent Filing Shows That Rep. Thomas Kean Sold Over $1K Worth of Franklin Resources Stock

<p>An official report on January 22, 2025 reveals Representative Thomas Kean's recent purchase of Canadian Pacific Kansas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CP#NYSE">CP</a>) stock, valued between $1,001 and $15,000. The transaction took place on January 22, 2025, as per the January filing.</p>
<p>At this time, Canadian Pacific Kansas shares are trading up 0.74% at $79.0.</p>
<h3>Representative's Recent Trading Activity</h3>
<p>In the past three years, Thomas Kean made 68 stock trades totaling more than $320 thousand. The largest trades involved stocks like Aon and Johnson &amp; Johnson. Their most notable trades made recently include key transactions: </p>
<ul>
<li><strong>Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYK#NASDAQ">LBTYK</a>):</strong> $15,001 - $50,000 Purchase</li>
<li><strong>Canadian Pacific Kansas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CP#NYSE">CP</a>):</strong> $1,001 - $15,000 Purchase</li>
<li><strong>Pernod Ricard (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PRNDY#OTC">PRNDY</a>):</strong> $1,001 - $15,000 Sale</li>
</ul>
<p>Here's a summary of Thomas Kean's recent trades:</p>
<table>
<thead>
<tr>
<th><strong>Company</strong></th>
<th><strong>Ticker</strong></th>
<th><strong>Stock Type</strong></th>
<th><strong>Amount</strong></th>
<th><strong>Transaction Type</strong></th>
<th><strong>Transaction Date</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Canadian Pacific Kansas</td>
<td>CP</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-27</td>
</tr>
<tr>
<td>Pernod Ricard</td>
<td>PRNDY</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S</td>
<td>2024-12-27</td>
</tr>
<tr>
<td>Alphabet</td>
<td>GOOG</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S</td>
<td>2024-12-19</td>
</tr>
<tr>
<td>Abbott Laboratories</td>
<td>ABT</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-16</td>
</tr>
<tr>
<td>Franklin Resources</td>
<td>BEN</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S (Partial)</td>
<td>2024-12-16</td>
</tr>
</tbody>
</table>
<p>If you want to stay updated on Thomas Kean's trades and other congressional members, check out our <a href="https://www.benzinga.com/gov-trades/members/thomas-kean"><strong>government trades tool</strong></a> to track their activity in real time!</p>
<h3>The Importance of Congressional Transactions</h3>
<p>A congressional transaction is when any representative or senator either buys or sells an individual stock.</p>
<p>Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.</p>
<p>In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.</p>
<h3>Why Congressional Transactions Matter</h3>
<p>Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.</p>
<p>When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.</p>
<p>A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


New Jersey Rep. Thomas Kean Bought Over $1K Worth of Canadian Pacific Kansas Stock: Here's What You Should Know

<p>January 22, 2025 records indicate that Representative Thomas Kean filed a purchase of Analog Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>), valued between $1,001 and $15,000. According to the January filing, the transaction occurred on January 22, 2025.</p>
<p>Currently, Analog Devices shares are trading down 0.14% at $223.76.</p>
<h3>What Representative Has Been Trading Recently</h3>
<p>In the last three years, Thomas Kean completed 68 stock transactions totaling more than $320 thousand. Aon and Johnson &amp; Johnson stocks were among the largest trades. Some of the most notable transactions the Rep. has executed recently include: </p>
<ul>
<li><strong>Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYK#NASDAQ">LBTYK</a>):</strong> $15,001 - $50,000 Purchase</li>
<li><strong>Canadian Pacific Kansas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CP#NYSE">CP</a>):</strong> $1,001 - $15,000 Purchase</li>
<li><strong>Pernod Ricard (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PRNDY#OTC">PRNDY</a>):</strong> $1,001 - $15,000 Sale</li>
</ul>
<p>Here's a summary of Thomas Kean's recent trades:</p>
<table>
<thead>
<tr>
<th><strong>Company</strong></th>
<th><strong>Ticker</strong></th>
<th><strong>Stock Type</strong></th>
<th><strong>Amount</strong></th>
<th><strong>Transaction Type</strong></th>
<th><strong>Transaction Date</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Canadian Pacific Kansas</td>
<td>CP</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-27</td>
</tr>
<tr>
<td>Pernod Ricard</td>
<td>PRNDY</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S</td>
<td>2024-12-27</td>
</tr>
<tr>
<td>Alphabet</td>
<td>GOOG</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S</td>
<td>2024-12-19</td>
</tr>
<tr>
<td>Abbott Laboratories</td>
<td>ABT</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-16</td>
</tr>
<tr>
<td>Franklin Resources</td>
<td>BEN</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S (Partial)</td>
<td>2024-12-16</td>
</tr>
</tbody>
</table>
<p>Stay informed on Thomas Kean's trades and other members of Congress with our real-time <a href="https://www.benzinga.com/gov-trades/members/thomas-kean"><strong>government trades tracking tool</strong></a>!</p>
<h3>Why Congressional Transactions Matter</h3>
<p>A congressional transaction is when any representative or senator either buys or sells an individual stock.</p>
<p>Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.</p>
<p>In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.</p>
<h3>The Importance of Congressional Transactions</h3>
<p>Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.</p>
<p>When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.</p>
<p>A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Recent Report Shows That Rep. Thomas Kean Bought Up to $15K Worth of Analog Devices Stock

<p>January 22, 2025 records indicate that Representative Thomas Kean filed a purchase of Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>), valued between $1,001 and $15,000. According to the January filing, the transaction occurred on January 22, 2025.</p>
<p>Currently, Abbott Laboratories shares are trading up 2.78% at $121.05.</p>
<h3>What Representative Has Been Trading Recently</h3>
<p>In the past three years, Thomas Kean made 68 stock trades totaling more than $320 thousand. The largest trades involved stocks like Aon and Johnson &amp; Johnson. Their most notable trades made recently include key transactions: </p>
<ul>
<li><strong>Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYK#NASDAQ">LBTYK</a>):</strong> $15,001 - $50,000 Purchase</li>
<li><strong>Canadian Pacific Kansas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CP#NYSE">CP</a>):</strong> $1,001 - $15,000 Purchase</li>
<li><strong>Pernod Ricard (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PRNDY#OTC">PRNDY</a>):</strong> $1,001 - $15,000 Sale</li>
</ul>
<p>Here's a summary of Thomas Kean's recent trades:</p>
<table>
<thead>
<tr>
<th><strong>Company</strong></th>
<th><strong>Ticker</strong></th>
<th><strong>Stock Type</strong></th>
<th><strong>Amount</strong></th>
<th><strong>Transaction Type</strong></th>
<th><strong>Transaction Date</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Canadian Pacific Kansas</td>
<td>CP</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-27</td>
</tr>
<tr>
<td>Pernod Ricard</td>
<td>PRNDY</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S</td>
<td>2024-12-27</td>
</tr>
<tr>
<td>Alphabet</td>
<td>GOOG</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S</td>
<td>2024-12-19</td>
</tr>
<tr>
<td>Abbott Laboratories</td>
<td>ABT</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-16</td>
</tr>
<tr>
<td>Franklin Resources</td>
<td>BEN</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S (Partial)</td>
<td>2024-12-16</td>
</tr>
</tbody>
</table>
<p>To keep an eye on Thomas Kean's trades and other government stock activity, check out our <a href="https://www.benzinga.com/gov-trades/members/thomas-kean"><strong>real-time tracking tool</strong></a>!</p>
<h3>The Importance of Congressional Transactions</h3>
<p>A congressional transaction is when any representative or senator either buys or sells an individual stock.</p>
<p>Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.</p>
<p>In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.</p>
<h3>The Importance of Congressional Transactions</h3>
<p>Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.</p>
<p>When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.</p>
<p>A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Congressional Trading Report: Rep. Thomas Kean Bought Over $1K In Abbott Laboratories Stock

Earnings

LBTYA

LBTYB

Liberty Global Q3 Consolidated Revenue On A Rebased Basis $1.8545B

Liberty Global Initiates Reopening Of Acceptance Period For Voluntary Unconditional Takeover Bid On Telenet Group

<p>&nbsp;<a href="https://apc01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.libertyglobal.com%2F&amp;data=05%7C01%7Cdena.tahmasebi%40infosys.com%7C6394344fe01443015f8608db9c1d7cf0%7C63ce7d592f3e42cda8ccbe764cff5eb6%7C0%7C0%7C638275422718747167%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=cCKZyKdJ02udNz4razyE%2FUdh%2FYXq4UXMG7srvsjqPU8%3D&amp;reserved=0" target="_blank">Liberty Global plc</a>&nbsp;(&#39;Liberty Global&#39;) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYA#NASDAQ">LBTYA</a>), (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYB#NASDAQ">LBTYB</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYK#NASDAQ">LBTYK</a>), one of the world&#39;s leading converged video, broadband and communications companies, and&nbsp;<a href="http://www.infosys.com/" target="_blank">Infosys</a>&nbsp;(NSE: INFY), (BSE: INFY), (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFY#NYSE">INFY</a>), a global leader in next-generation digital services and consulting, today announced that they have expanded their collaboration to evolve and scale Liberty Global&#39;s cutting-edge digital entertainment and connectivity platforms.</p>


INFY

Liberty Global and Infosys Expand Collaboration to Bring AI-Powered Digital Entertainment to Customers Worldwide

<ul>
<li>Keybanc boosted the price target for <strong> Micron Technology, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mu#NASDAQ">MU</a>) from $70 to $80. Keybanc analyst John Vinh maintained an Overweight rating. Micron shares rose 3.9% to $69.70 in pre-market trading.</li>
<li>Credit Suisse cut the price target for <strong> Pfizer Inc. </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pfe#NYSE">PFE</a>) from $47 to $40. Credit Suisse analyst Trung Huynh downgraded the stock from Outperform to Neutral. Pfizer shares fell 0.7% to $36.02 in pre-market trading.</li>
<li>Pivotal Research slashed the price target for <strong> Liberty Global plc </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lbtyk#NASDAQ">LBTYK</a>) from $30 to $25. Pivotal Research analyst Jeffrey Wlodarczak maintained a Buy rating. Liberty Global shares fell 1.3% to close at $17.89 on Wednesday.</li>
<li>Keefe, Bruyette &amp; Woods lifted <strong> Green Dot Corporation </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gdot#NYSE">GDOT</a>) price target from $17 to $20. Keefe, Bruyette &amp; Woods analyst Michael Perito maintained the stock with a Market Perform rating. Green Dot shares rose 1.8% to close at $18.61 on Wednesday.</li>
<li>Goldman Sachs cut <strong> Foghorn Therapeutics Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fhtx#NASDAQ">FHTX</a>) price target from $21 to $19. Goldman Sachs analyst Paul Choi maintained a Buy rating. Foghorn Therapeutics shares rose 2.4% to close at $8.60 on Wednesday.</li>
<li>HC Wainwright &amp; Co. boosted <strong> Roivant Sciences Ltd. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roiv#NASDAQ">ROIV</a>) price target from $15 to $18. HC Wainwright &amp; Co. analyst Douglas Tsao maintained a Buy rating. Roivant Sciences shares fell 1.2% to $9.95 in pre-market trading.</li>
<li>Morgan Stanley raised<strong> Schr&ouml;dinger, Inc. </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sdgr#NYSE">SDGR</a>) price target from $38 to $52. Morgan Stanley analyst Vikram Malhorta maintained an Equal-Weight rating. Schr&ouml;dinger shares rose 1.9% to $45.64 in pre-market trading.</li>
<li>UBS raised the price target for <strong> Symbotic Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sym#NASDAQ">SYM</a>) from $34 to $40. UBS analyst Chris Snyder downgraded the stock from Buy to Neutral. Symbotic shares rose 0.4% to $42.00 in pre-market trading.</li>
<li>Morgan Stanley lowered <strong> General Mills, Inc. </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gis#NYSE">GIS</a>) price target from $77 to $72. Morgan Stanley analyst Pamela Kaufman maintained an Underweight rating. General Mills shares fell 0.1% to $76.65 in pre-market trading.</li>
<li>B of A Securities boosted <strong> The RealReal, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/real#NASDAQ">REAL</a>) price target from $1 to $1.85. B of A Securities analyst Michael McGovern upgraded the stock from Underperform to Neutral. RealReal shares rose 2.2% to $1.85 in pre-market trading.</li>
<li>Keybanc raised <strong> Invitation Homes Inc. </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/invh#NYSE">INVH</a>) price target from $35 to $37. Keybanc analyst Austin Wurschmidt maintained an Overweight rating. Invitation Homes shares rose 0.6% to close at $34.26 on Wednesday.</li>
</ul>
<p>&nbsp;</p>
<p>Check This Out: <a href="https://www.benzinga.com/news/23/06/33057441/uber-on-semiconductor-and-2-other-stocks-insiders-are-selling"><em> Uber, ON Semiconductor And 2 Other Stocks Insiders Are Selling </em></a></p>


Penny Stocks

Price Target

Small Cap

Pre-Market Outlook

Markets

Analyst Ratings

FHTX

GDOT

INVH

REAL

ROIV

SDGR

Schrödinger To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday

<p>Pivotal Research  analyst Jeffrey Wlodarczak   maintains Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYK#NASDAQ">LBTYK</a>) with a Buy and lowers the price target from $30 to $25.</p>


Pivotal Research Maintains Buy on Liberty Global, Lowers Price Target to $25

<p>Pivotal Research  analyst Jeffrey Wlodarczak   maintains Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYK#NASDAQ">LBTYK</a>) with a Buy and lowers the price target from $33 to $30.</p>


Pivotal Research Maintains Buy on Liberty Global, Lowers Price Target to $30

<p>If history is any guide, there may be good fortune ahead for shares of <strong>Liberty Global</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYK#NASDAQ">LBTYK</a>).  A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.</p>
<p><strong>What To Know:</strong> Many traders use moving average crossover systems to make their decisions.</p>
<p>When a shorter-term average price crosses above a longer-term average price, it could mean the stock is trending higher. If the short-term average price crosses below the long-term average price, it means the trend is lower.</p>
<p><strong>Why It's Important:</strong> The 50-day and the 200-day simple moving averages are commonly used. </p>
<p>The golden cross occurs when the 50-day crosses above the 200-day. This could mean the long-term trend is changing.</p>
<p>That just happened with Liberty Global, which is trading around $21.68 at publication time.</p>
<p><img src="https://www.benzinga.com/files/images/story/2023/1677250060_0.png" alt="signals" /></p>
<p><strong>Remember:</strong> Seasoned investors don't blindly trade Golden Crosses.</p>
<p>Instead, they use it as a signal to start looking for long positions based on other factors, like price levels and company fundamentals &amp; events.</p>
<p>For seasoned investors, this is just a sign that it might be time to start considering possible long positions. </p>
<p>[TABLE]</p>
<p>Do you use the Golden Cross signal in your trading or investing? Share this article with a friend if you found it helpful!</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Movers

Will Investors Notice Exciting Sign On Liberty Global's Chart?

WIIM

AMCX

ASTS

BAND

BMBL

CABO

CDLX

CHTR

CMCSA

DISH

EVER

FAZE

FOXA

GOOG

GOOGL

IHRT

KBNT

LBRDA

LBRDK

LFLY

LTRPB

MGNI

MOMO

MTCH

MYPS

NCMI

NFLX

NTES

NWSA

PARA

PARAA

PINS

PLTK

RBLX

ROKU

RSVR

SNAP

SPOT

STBX

TBLA

TRIP

TRKA

TRUE

TTGT

TTWO

TZOO

WLYB

YALA

Shares of several companies in the broader communications, media & entertainment industry are trading higher as stocks gain following Thursday's CPI report. Lighter-than-expected inflation has led to hopes of softer Fed rate hikes, which could cause less of a negative impact on consumer spending.

<p>Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYA#NASDAQ">LBTYA</a>) reported quarterly sales of $1.75 billion which beat the analyst consensus estimate of $1.72 billion by 1.51 percent.  This is a 8.15 percent decrease over sales of $1.90 billion the same period last year.</p>


Liberty Global Q3 Sales $1.75B Beat $1.72B Estimate

ATHM

FUBO

OOMA

TIGO

Shares of companies in the broader communications, media & entertainment industry are trading higher as stocks rebound following September weakness stemming from concerns over inflation, contractionary Fed policy and a potential recession.

Options

KNDI

KSPN

KTOS

Kintara Therapeutics, Inc. - Common Stock

KTRA

KXIN

LAKE

LILA

LILAK

LILM

LIZI

LOCO

LUCY

MAXR

MEGL

MGAM

MIND

MINM

MITT

MKTX

MNOV

MRVI

MUFG

NATR

NBEV

NBRV

NODK

NOMD

NVAX

NVEI

OPAD

ORGO

OSPN

OTEX

PATH

PBFS

PDCO

PESI

PLBY

POWW

PRIM

PROF

PTPI

PXLW

PYPD

Qualigen Therapeutics, Inc. - Common Stock

QLGN

RAMP

RBCN

REBN

RGTI

RKLY

RNLX

SATS

SCCO

SCPS

SDIG

SITM

SKIL

SMFR

SMPL

Sony Group Corporation American Depositary Shares

SONY

SQFT

STIX

SWKH

TCBP

TESS

TOPS

TROX

Stocks That Hit 52-Week Lows On Wednesday

<p>Pivotal Research  analyst Jeffrey Wlodarczak   maintains Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYK#NASDAQ">LBTYK</a>) with a Buy and lowers the price target from $38 to $35.</p>


Pivotal Research Maintains Buy on Liberty Global, Lowers Price Target to $35

ANGI

ANTE

BHAT

BIDU

BILI

DOYU

FYBR

GOGO

HUYA

LSXMA

LSXMK

LUMN

MOBQ

PGRU

PTNR

SBGI

STGW

STRY

Shares of companies in the broader communications, media and entertainment industry are trading lower amid overall market weakness as stocks move lower following Wednesday's Fed rate hike decision, which has pressured markets.

Comments

Liberty Global

Actualités

Dernières nouvelles pour Liberty Global (NASDAQ:LBTYK) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL